Stancato L - Search Results

1

Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.

Ricci-Vitiani L, Runci D, D'Alessandris QG, Cenci T, Martini M, Bianchi F, Maira G, Stancato L, De Maria R, Larocca LM, Pallini R. Ricci-Vitiani L, et al. Among authors: stancato l. Neoplasia. 2013 Jul;15(7):773-82. doi: 10.1593/neo.13150. Neoplasia. 2013. PMID: 23814489 Free PMC article.

2

Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo.

Signore M, Pelacchi F, di Martino S, Runci D, Biffoni M, Giannetti S, Morgante L, De Majo M, Petricoin EF, Stancato L, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L. Signore M, et al. Among authors: stancato l. Cell Death Dis. 2014 May 8;5(5):e1223. doi: 10.1038/cddis.2014.188. Cell Death Dis. 2014. PMID: 24810059 Free PMC article.

3

A BMP7 Variant Inhibits Tumor Angiogenesis In Vitro and In Vivo through Direct Modulation of Endothelial Cell Biology.

Tate CM, Mc Entire J, Pallini R, Vakana E, Wyss L, Blosser W, Ricci-Vitiani L, D'Alessandris QG, Morgante L, Giannetti S, Larocca LM, Todaro M, Benfante A, Colorito ML, Stassi G, De Maria R, Rowlinson S, Stancato L. Tate CM, et al. Among authors: stancato l. PLoS One. 2015 Apr 28;10(4):e0125697. doi: 10.1371/journal.pone.0125697. eCollection 2015. PLoS One. 2015. PMID: 25919028 Free PMC article.

4

The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response.

D'Alessandris QG, Biffoni M, Martini M, Runci D, Buccarelli M, Cenci T, Signore M, Stancato L, Olivi A, De Maria R, Larocca LM, Ricci-Vitiani L, Pallini R. D'Alessandris QG, et al. Among authors: stancato l. Neuro Oncol. 2017 Aug 1;19(8):1097-1108. doi: 10.1093/neuonc/now304. Neuro Oncol. 2017. PMID: 28204560 Free PMC article.

5

Glioblastoma endothelium drives bevacizumab-induced infiltrative growth via modulation of PLXDC1.

Falchetti ML, D'Alessandris QG, Pacioni S, Buccarelli M, Morgante L, Giannetti S, Lulli V, Martini M, Larocca LM, Vakana E, Stancato L, Ricci-Vitiani L, Pallini R. Falchetti ML, et al. Among authors: stancato l. Int J Cancer. 2019 Mar 15;144(6):1331-1344. doi: 10.1002/ijc.31983. Epub 2018 Dec 16. Int J Cancer. 2019. PMID: 30414187 Free PMC article.

6

A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.

Tate CM, Pallini R, Ricci-Vitiani L, Dowless M, Shiyanova T, D'Alessandris GQ, Morgante L, Giannetti S, Larocca LM, di Martino S, Rowlinson SW, De Maria R, Stancato L. Tate CM, et al. Among authors: stancato l. Cell Death Differ. 2012 Oct;19(10):1644-54. doi: 10.1038/cdd.2012.44. Epub 2012 Apr 27. Cell Death Differ. 2012. PMID: 22539003 Free PMC article.

7

Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.

Veschi V, Mangiapane LR, Nicotra A, Di Franco S, Scavo E, Apuzzo T, Sardina DS, Fiori M, Benfante A, Colorito ML, Cocorullo G, Giuliante F, Cipolla C, Pistone G, Bongiorno MR, Rizzo A, Tate CM, Wu X, Rowlinson S, Stancato LF, Todaro M, De Maria R, Stassi G. Veschi V, et al. Among authors: stancato lf. Oncogene. 2020 Jan;39(5):987-1003. doi: 10.1038/s41388-019-1047-4. Epub 2019 Oct 7. Oncogene. 2020. PMID: 31591478 Free PMC article.

8

Knockdown of ubiquitin ligases in glioblastoma cancer stem cells leads to cell death and differentiation.

Low J, Blosser W, Dowless M, Ricci-Vitiani L, Pallini R, de Maria R, Stancato L. Low J, et al. Among authors: stancato l. J Biomol Screen. 2012 Feb;17(2):152-62. doi: 10.1177/1087057111422565. Epub 2011 Sep 28. J Biomol Screen. 2012. PMID: 21956171

9

Knockdown of cancer testis antigens modulates neural stem cell marker expression in glioblastoma tumor stem cells.

Low J, Dowless M, Shiyanova T, Rowlinson S, Ricci-Vitiani L, de Maria R, Pallini R, Stancato L. Low J, et al. Among authors: stancato l. J Biomol Screen. 2010 Aug;15(7):830-9. doi: 10.1177/1087057110374983. Epub 2010 Jul 16. J Biomol Screen. 2010. PMID: 20639497

10

LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer.

Vakana E, Pratt S, Blosser W, Dowless M, Simpson N, Yuan XJ, Jaken S, Manro J, Stephens J, Zhang Y, Huber L, Peng SB, Stancato LF. Vakana E, et al. Among authors: stancato lf. Oncotarget. 2017 Feb 7;8(6):9251-9266. doi: 10.18632/oncotarget.14002. Oncotarget. 2017. PMID: 27999210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters